October’s Journal of Drugs in Dermatology Editor’s Picks offer an exciting look into cutting-edge research, with a special focus on atopic dermatitis and several related skin conditions. This month’s selections dive deep into groundbreaking studies, ranging from innovative treatments for acne and environmental skin aging to advancements in hyperhidrosis research using machine learning models. Notably, the featured articles explore the safety and efficacy of therapies for atopic dermatitis and discuss the clinical application of JAK inhibitors as emerging options in dermatology. Whether you’re interested in patient adherence, novel skincare regimens, or predictive analytics, these articles provide invaluable insights for advancing dermatological care.
Predictive Machine Learning-Based Classification Models surveys 637
sufferers to assess hyperhidrosis and sensitive skin symptom burden.
for Male and Female Acne: Phase 3 Analysis demonstrates comparable efficacy, quality-of-life improvements, and safety in female and male participants with moderate-to-severe acne
Improving Environmental Skin Aging evaluates the clinical benefits of a daily
regimen designed to provide comprehensive environmental protection and repair environmentally damaged skin.
Versus Layered Topicals for Acne: Split-Face Study analyzes how simplifying
acne treatment with fixed-dose topical combinations can improve patience
treatment adherence.
dermatology toolbox, with impressive efficacy and favorable safety and
tolerability profile.
the AAD Guidelines address how proactive treatment for AD may optimize
disease management and prevent flares.
Find more JDD Issue Highlights here.
